Kuros Biosciences AG
CSBTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $762,112 | $118,413 | $60,152 | $76,238 |
| - Cash | $17,460 | $14,208 | $24,065 | $28,623 |
| + Debt | $1,793 | $2,143 | $1,913 | $2,146 |
| Enterprise Value | $746,445 | $106,348 | $38,000 | $49,761 |
| Revenue | $75,555 | $33,564 | $17,986 | $13,815 |
| % Growth | 125.1% | 86.6% | 30.2% | – |
| Gross Profit | $62,031 | $28,471 | $10,769 | $10,066 |
| % Margin | 82.1% | 84.8% | 59.9% | 72.9% |
| EBITDA | -$561 | -$7,494 | -$7,500 | -$5,291 |
| % Margin | -0.7% | -22.3% | -41.7% | -38.3% |
| Net Income | -$3,716 | -$13,727 | -$14,595 | -$7,541 |
| % Margin | -4.9% | -40.9% | -81.1% | -54.6% |
| EPS Diluted | -0.1 | -0.38 | -0.43 | -0.23 |
| % Growth | 73.7% | 11.6% | -87% | – |
| Operating Cash Flow | $3,140 | -$8,844 | -$7,348 | -$5,453 |
| Capital Expenditures | -$1,112 | -$326 | -$400 | -$374 |
| Free Cash Flow | $2,028 | -$9,170 | -$7,748 | -$5,827 |